Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Trial record 2 of 61 for:    IL-2 SELECT

IL-2 "SELECT" Tissue Collection Protocol in Patients With Advanced Melanoma

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2015 by Dana-Farber Cancer Institute
Sponsor:
Information provided by (Responsible Party):
David F. McDermott, MD, Dana-Farber Cancer Institute
ClinicalTrials.gov Identifier:
NCT01288963
First received: February 1, 2011
Last updated: January 26, 2015
Last verified: January 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: February 2017
  Estimated Primary Completion Date: February 2016 (Final data collection date for primary outcome measure)